Background: Current surveillance protocols after endovascular aneurysm repair (EVAR) are ineffective and costly. Stratifying surveillance by individual risk of reintervention requires an understanding of the factors involved in developing post-EVAR complications. This systematic review assessed risk factors for reintervention after EVAR and proposals for stratified surveillance. Methods: A systematic search according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was performed using EMBASE and MEDLINE databases to identify studies reporting on risk factors predicting reintervention after EVAR and proposals for stratified surveillance. Results: Twenty-nine studies reporting on 39 898 patients met the primary inclusion criteria for reporting predictors of reintervention or aortic complications with or without suggestions for stratified surveillance. Five secondary studies described external validation of risk scores for reintervention or aortic complications. There was great heterogeneity in reporting risk factors identified at the pre-EVAR, intraoperative, and post-EVAR stages of treatment, although large preoperative abdominal aortic aneurysm diameter was the most commonly observed risk factor for reintervention after EVAR. Conclusion: Existing data on predictors of post-EVAR complications are generally of poor quality and largely derived from retrospective studies. Few studies describing suggestions for stratified surveillance have been subjected to external validation. There is a need to refine risk prediction for EVAR failure and to conduct prospective comparative studies of personalized surveillance with standard practice.
Introduction
Endovascular repair of abdominal aortic aneurysms (AAAs; endovascular aneurysm repair [EVAR] ) is associated with a reintervention rate of up to 20% in the first 5 years. [1] [2] [3] These reinterventions are primarily performed to treat the sequelae of EVAR that would otherwise lead to late aneurysm rupture. Lifelong endograft surveillance is therefore currently considered essential. 4 However, the efficacy of surveillance protocols after EVAR remains poor and there is considerable heterogeneity in current practice. 5, 6 The majority of reinterventions occur as a result of symptomatic presentation between apparently normal surveillance scans, rather than as a result of the detection of abnormalities on routine surveillance. 7, 8 Furthermore, lifelong surveillance is associated with significant costs [9] [10] [11] [12] and affects quality of life for patients, which is reflected by poor compliance. 13, 14 This has stimulated interest in research to inform the timing (intensity) of surveillance after EVAR, with the goal of offering personalized surveillance. Stratifying surveillance for individuals could theoretically improve clinical effectiveness, cost effectiveness, and compliance in the years following EVAR but requires a reproducible understanding of the factors associated with device failure and reintervention. Separate studies have attempted to define the procedural factors associated with different types of reintervention after EVAR, and thereby define the evidence that should underpin stratified surveillance. However, the evidence as a whole has not been subject to summative critical analysis. This study aims to systematically review the evidence to identify preoperative, intraoperative, and postoperative factors that predict
Results of the Literature Search
The literature search identified 660 initial abstracts, of which 94 full texts were assessed for eligibility ( Figure 1 , PRISMA flowchart). Twenty-nine primary studies met the inclusion criteria for reporting predictors of reintervention or aortic complications, with or without suggestions for stratified surveillance. 8, Five secondary studies described external validation of risk scores for reintervention or aortic complications. 43, [46] [47] [48] [49] The 29 primary studies reported 39 898 patients, with study midpoints ranging from 1998 to 2011. Predictors of aortic complications and reintervention were identified from preoperative, intraoperative, and postoperative EVAR data (Table 1) . These are explored separately, and further detail in the Discussion section. Short-term and mid-term results were reported, with median follow-up ranging from 0.9 to 4.3 years.
Study Quality
There was considerable variation in study quality. All were cohort studies or case-control design and classified as 2þ according to the SIGN hierarchy of evidence scale, where level 1þþ refers to systematic review, meta-analyses of randomized controlled trials or randomized controlled trials of low levels of bias, and where level 4 refers to expert opinion. Two studies were retrospective analyses of the EVAR 1 and EVAR 2 randomized controlled trials, which provided data from level 1þ studies 24, 44 ; but were utilized for post hoc comparison and therefore subject to the same limitations of other cohort study designs.
Discussion

Preoperative Predictors of Aortic Complications or Reintervention
Sixteen of 29 studies 18, 21, 22, 24, [26] [27] [28] 31, 33, 34, [36] [37] [38] [39] 43 ,44 of 30 057 patients described preoperative predictors of late aortic complications after EVAR (Table 2 ). 
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Vascular and Endovascular Surgery 51(6) Vascular and Endovascular Surgery 51 (6) Preoperative AAA diameter 21, 22, 24, 27, 31, 36, 37 was the most commonly observed risk factor for reintervention after EVAR; reported in 7 studies of 7803 patients. The largest of these was a retrospective analysis of 4392 patients from over 100 centers in the European Collaborators on Stent-Graft Techniques for Abdominal Aortic Aneurysm Repair (EUROSTAR) database, a multi-European center registry, with a mean follow-up of 18.4 months. Multivariate analysis demonstrated that preoperative AAA > 65 mm was associated with a greater number of type 1A endoleaks than 55 to 65 mm AAA (freedom from endoleak at 4 years: 89.5% vs 95.1%, P ¼ .002). 36 A study of 761 patients at 2 UK centers demonstrated that AAA diameter and Common Iliac Artery (CIA) diameter were significantly greater in patients who developed aortic complications (71 vs 62.2 mm, P < .001; and 20.3 vs 18.8 mm, P ¼ 0.003, respectively) 31 and were independent predictors of reintervention. Six studies of 12 463 patients 24, 31, 34, 38, 43, 44 reported that common iliac artery morphology was associated with endograftrelated aortic complication. In post hoc analysis of the EVAR 1 and EVAR 2 trials, 24, 44 Wyss et al 44 demonstrated that endograft complications were associated with the greater common iliac artery thrombus, calcification, and tortuosity (hazard ratios: 1.04 (P ¼ .011), 0.96 (P ¼ .033), and 5.96 (P ¼ .01), respectively) while Brown et al 24 reported that larger common iliac artery diameter and larger AAA diameter were both associated with more frequent endograft complications in the follow-up of EVAR 1 and EVAR 2 patients (hazard ratios: 1.69 (P ¼ .011) and 1.32 (P < .001), respectively). These findings mirrored the components of the St George's Vascular Institute (SGVI) risk score, which combined AAA diameter and CIA diameter 31 to dichotomize patients into groups at low risk or high risk for aortic complication after EVAR.
Age was associated with endograft complications in the EVAR 1 and EVAR 2 trials, and was also associated with sac expansion in an analysis of over 10 000 patients recorded by the M2S database. 38 In this analysis, aneurysm sac enlargement after EVAR was associated with an age >80 and common iliac artery diameter >20 mm by multivariate analysis (hazard ratios: 1.32 (P ¼ .05) and 1.46 (P < .0001), respectively).
Various aspects of neck morphology were associated in isolation with aortic complications and particularly proximal type 1 endoleak, but other studies reported an inconsistent relationship with overall reintervention rate after EVAR. Reinterventions were associated with shorter neck length (5 studies) 18, 21, 33, 39, 44 or greater neck angulation (5 studies), 21, 28, 38, 39, 44 diameter (3 studies), 21, 38, 39 or calcification (2 studies) 27, 37 by some studies, but other studies demonstrated no independent association of neck diameter, 24, 34 angulation, 31, 34 or length 34 with reintervention rates or aortic complication rates.
Three studies proposed "risk scores" based on preoperative variables. 21, 31, 39 The Endovascular Risk Assessment Model, devised from audit data in Australia, combined 8 preoperative variables (age, maximal AAA diameter, ASA, gender, creatinine, neck angle, neck length, and neck diameter) and was designed to predict the incidence of type I endoleak and reintervention after EVAR. 21 It demonstrated inconsistent success when validated against both national and international cohorts. 43, 46 In the largest of these (an international data set of 433 consecutive patients from Europe), accuracy of the score was shown to be poor (area under ROC curve between 0.47 and 0.61. A total of 0.7 is considered the threshold for sufficient accuracy to inform decision-making). 48 The Siena EVAR score, derived from the data of 976 patients, was a predictive model for reintervention, combining neck morphology and operator experience with renal function. The authors reported 81.5% sensitivity and 84.1% specificity, but have not examined external validity or reproducibility, and the score has not been tested beyond 1-year mean follow-up. The SGVI score was derived from aortic morphology data in over 400 patients treated at 1 UK center and was externally validated using a cohort of over 280 patients treated at a second UK center. The scoring system coupled maximum aneurysm diameter with maximal common iliac artery diameter to predictively dichotomize patients into high-risk and low-risk groups, and performed well in the external validation test, with observed 5-year freedom from aortic complications of 88% versus 69%, respectively, for those predicted to be at low risk or high risk for device failure. 31 The SGVI score has subsequently been further validated with data from the multicenter ENGAGE registry in over 1000 patients with at least 3-year follow-up data, where the group with larger AAA and CIA diameters had a significantly higher incidence of reintervention at 3 years (21.7% vs 9.5% in survival analysis, P < .001). 47 Overall, there has been extensive reporting of preoperative risk factors for mid-term EVAR complications. This included results from retrospective analysis of randomized controlled trial data. The AAA diameter and common iliac artery morphology were the most commonly and most consistently reported preoperative risk factors. The SGVI score combined these 2 factors and has been subject to a number of successful external validation studies. Other scoring systems have either failed to perform in external validation data sets or are yet to be subjected to external validation.
Intraoperative Predictors of Aneurysm-Related Morbidity
Five of 29 studies (a total of 3225 patients) 8, 19, 20, 25, 45 reported a higher rate of reintervention after the use of intraoperative adjuncts (Table 3) . Three studies reported outcomes in cases using stent grafts within Instructions For Use (IFU) guidelines versus cases in which the use was outside of IFU. The largest of these, a retrospective analysis of 552 single-unit cases, demonstrated a higher rate of late type 1 endoleaks (9.5% vs 4.5%, P ¼ .02) and reinterventions (22.8% vs 11.0%, P < .01) in cases where "hostile neck anatomy" required the use of grafts outside of IFU. Deeper analysis suggested that increased neck diameter was the key contributor to these findings. Using a stent graft outside of IFU is not an independent predictor for morbidity; rather, it is a surrogate marker for complex preoperative aneurysm morphology. This is supported by data from Abbruzzese et al 19 and Torsello et al, 20 where EVAR performed outside of IFU was associated with higher rates of aneurysm-related complications but also with larger aortic diameters, great neck diameters, shorter necks, and greater neck angulation. This lends strength to our review's major finding that preoperative morphological factors are the greatest influence on later complications. In an analysis of over 1000 patients, Byrne et al demonstrated a greater incidence of endoleak and reintervention in individuals requiring intraoperative Palmaz stent deployment (44% vs 30%, P ¼ .0004). 25 Karthikesalingam et al duplicated this finding and additionally reported a higher rate of reintervention where EVAR was extended into the external iliac artery without concomitant deployment of an adjunctive self-expanding stent (P ¼ .014). 8 Overall, there was a paucity of data to examine the effect of intraoperative/procedural variables on late aortic complications and reintervention after EVAR. There was little evidence to examine the potential role of varied oversizing of the stentgraft relative to seal zones or for comparing the reintervention rate associated with different endograft manufacturer/models. No studies have reproducibly attempted to link procedural complexity or surrogate markers of technical expertise (case volume, procedural time, contrast/radiation dose) to late reintervention.
Post-EVAR Predictors of Aneurysm-Related Morbidity
Twelve of 29 studies 22, 23, 26, 27, 29, 30, 32, 35, 38, [40] [41] [42] reported postoperative predictors of reintervention after EVAR (Table 4) . Abnormal findings from early post-EVAR surveillance scans were correlated with both aneurysm-related complications and reintervention, including lack of sac regression (3 studies, 1145 patients), 22 ,29,32 observed endoleak (5 studies, 16 242 patients), 26, 27, 30, 38, 42 or a combination of features (4 studies, 1600 patients), 23, 35, 40, 41 including inadequate sealing zones from postoperative imaging of device implantation.
The largest of these studies was an analysis of 10 228 patients from the M2S database. 38 Multivariate analysis revealed that the primary determinant of post-EVAR sac enlargement (5 mm increase in maximal diameter) was the presence of any endoleak on any postoperative scan (hazard ratio: 2.70, 95% confidence interval: 2.4-3.04, P < .0001). 38 The M2S database did not provide details of the different types of endoleak associated with sac expansion, or more details regarding the type/nature of reintervention that was associated with sac expansion, limiting the applicability of this finding to stratified surveillance protocols.
Endoleak was the most commonly reported postoperative predictor of late reintervention. A cox regression analysis of 1412 consecutive patients by Cieri et al reported that type II endoleak was an independent predictor of aneurysm growth; freedom from reintervention rates were 60.2% versus 94.9% at 5 years for patients with and without type II endoleak, respectively (P < .0001). 26 Jones et al described a poorer prognosis associated with persistent type II endoleak (one that does not resolve in <6 months). In a cohort of 164 patients, freedom from sac enlargement at 5 years was 94.9% in patients without this finding compared to 28% in those with it (P < .001). 30 A EUROSTAR registry study of 3595 patients published in 2004 also reported a significant increase in sac size and reinterventions for cases with type II endoleak as opposed to those without (55% at 3 years vs 15%, P < .0001). 42 However, these findings remain controversial, because it is well established that rupture after isolated type II endoleak is rare, many interventions to treat type II endoleak are unsuccessful, and sac expansion associated with type II endoleak may be the result of occult type I/III/IV endoleak. 50 Several studies reported the importance of a normal computed tomography (CT) scan performed 1 year after EVAR, in predicting low mid-term rates of aortic complication. In a study of 134 patients from Canada, 18 freedom from reintervention at 3 years was 96% in individuals with a normal first post-EVAR CT scan, and the authors proposed that further surveillance could be postponed until 3 years. Patel and Carpenter reported the negative predictive value of a normal first postoperative CT scan as 96.4% 35 and suggested replacing subsequent CT imaging with duplex ultrasound in such cases. The applicability of the finding is limited by the fact that only Powerlink (Endologix, California) stent-grafts were used in this series of 123 patients. Bastos Goncalves and colleagues suggested not imaging individuals if the first CT scan after EVAR was normal. 23 The development set for their study included 131 patients, across 2 centers in Portugal and Holland, treated with only the Excluder stent graft (W.L. Gore and Associates, Flagstaff, Arizona). Five-year freedom from aneurysm-related complications was 98% for individuals with adequate seal (10 mm) and no endoleak on the first postoperative CT scan (vs 52% for the comparator/high-risk group). However, in an external validation sample of 112 patients from the United Kingdom, the low-risk group exhibited an adverse event rate of 20.3% in lowrisk patients versus 51.5% in the high-risk group (odds ratio: 4.18, P < .001), concluding that the use of this risk factor profile to drive stratified surveillance was unfeasible. 49 Several studies investigated the lack of sac regression in predicting poor outcome after EVAR. In an international multicenter cohort of 597 patients, lack of sac shrinkage was an independent risk factor for late complications compared with major (10 mm reduction in maximal sac diameter) shrinkage (hazard ratio: 3.11; P < .001). 22 In a single-center cohort of 371 patients from France, type I endoleaks and reintervention rate were significantly lower in patients with "significant sac retraction" (2.2% and 3.3%, respectively) compared to those with nonsignificant sac retraction (15.4% and 13.3%, respectively), measured in this instance as a proportional decrease in maximal aortic diameter 29 . The most commonly reported postoperative risk factors for late EVAR failure were endoleak and lack of sac regression on early surveillance scans. Further research is required to clarify the potentially additive role of postoperative, intraoperative, and preoperative predictors of mid-term EVAR failure.
Suggestions for Stratified Surveillance
Thirteen of 29 studies [21] [22] [23] 27, [29] [30] [31] 35, 36, [39] [40] [41] [42] used the identified risk factors to suggest implications for surveillance (Table 5 ). In 6 of these studies, a specific stratified surveillance regime was suggested. 22, 23, 31, 35, 40, 41 Five of these were based on findings at the initial post-EVAR scan with subsequent relaxation of protocols based on normal imaging. Only 3 of the 13 studies attempted validation of stratified surveillance (Table 5) .
Sternberg et al proposed a surveillance protocol for Zenith endografts based on retrospective analysis of 739 patients. All patients would require contrast CT angiography and 4-view radiographs at 30-days post procedure. High-risk patients (defined as those with endoleak or a stent/artery overlap distance of <10 mm at 30 days) require contrast CT angiography every 6 to 12 months; low-risk patients (defined as those with a normal 30-day CT) require CT at 12 months, followed by annual duplex ultrasound. The authors acknowledged the subjective nature of these recommendations and proposed evaluation with a prospective randomized controlled trial.
The SGVI Score validation suggested that high-risk patients might best undergo 12 duplex ultrasound scans in 5 years, and lower-risk patients undergo 8 duplex ultrasound scans in the same time period. This would be cost neutral in comparison with current practice in one center, but the external validity of operator-dependent imaging in different clinical contexts remains unknown. Other surveillance strategies have been described earlier and center on cessation of surveillance after a normal early CT scan. 22, 23, 41 
Conclusion
Current heterogeneity in lifelong surveillance after EVAR is ineffective, costly, and may be associated with poor compliance. 13, 14, 51 The major finding of this review was that the existing data to examine stratified surveillance or predictors of aortic complication after EVAR are of poor quality and derive largely from retrospective studies. Preoperative anatomical factors seem to be commonly reported as being independently predictive of later morbidity, as compared to intraoperative and postoperative features. Few studies have been subject to external validation, and no prospective comparative data are available to examine efficacy. Only one model has been subject to successful external validation, but the rate of reintervention in patients predicted to be at the lowest risk remains unacceptable. Currently, we cannot recommend deviation away from national/international guidelinebased management in favor of stratified surveillance protocols. There is a need to refine risk prediction for EVAR failure, to attempt to integrate preoperative, intraoperative, and postoperative predictors of late endograft failure, to further analyze factors associated with patients' preferences for surveillance or compliance with protocol, and to conduct robust prospective comparative studies of personalized EVAR surveillance with standard practice.
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